Global burden of cirrhosis and liver cancer due to alcohol: the past, present, and the future.
作者信息
Xie Chencheng, Singal Ashwani K
机构信息
Department of Medicine, University of South Dakota Sanford School of Medicine, Vermillion, SD, USA.
Avera Transplant Institute and Division of Hepatology, Sioux Falls, SD, USA.
出版信息
Hepatol Int. 2023 Aug;17(4):830-832. doi: 10.1007/s12072-023-10534-9. Epub 2023 Apr 26.
Abstract
摘要
相似文献
1
Global burden of cirrhosis and liver cancer due to alcohol: the past, present, and the future.酒精所致肝硬化和肝癌的全球负担：过去、现在与未来
Hepatol Int. 2023 Aug;17(4):830-832. doi: 10.1007/s12072-023-10534-9. Epub 2023 Apr 26.
2
The global burden of liver disease: a challenge for methods and for public health.肝病的全球负担：对方法和公共卫生的一项挑战。
BMC Med. 2014 Sep 18;12:159. doi: 10.1186/s12916-014-0159-5.
3
Liver disease in alcohol and hepatitis C.酒精性肝病与丙型肝炎
Best Pract Res Clin Gastroenterol. 2003 Aug;17(4):649-62. doi: 10.1016/s1521-6918(03)00018-0.
4
Development and Validation of a Noninvasive Risk Score Model for Liver Cirrhosis in At-Risk Alcohol Drinkers Without HBV/HCV Infection.非 HBV/HCV 感染的高危饮酒者肝硬化无创风险评分模型的建立与验证。
Cancer Prev Res (Phila). 2022 Nov 1;15(11):767-776. doi: 10.1158/1940-6207.CAPR-22-0234.
5
Alcohol consumption increases the incidence of hepatocellular carcinoma in patients with hepatitis B cirrhosis but not in patients with hepatitis C cirrhosis.饮酒会增加乙型肝炎肝硬化患者肝细胞癌的发生率，但不会增加丙型肝炎肝硬化患者肝细胞癌的发生率。
Eur J Gastroenterol Hepatol. 2021 Sep 1;33(9):1218-1221. doi: 10.1097/MEG.0000000000001837.
6
Alcohol and liver cancer.酒精与肝癌
Eur J Cancer Prev. 2007 Dec;16(6):495-7. doi: 10.1097/CEJ.0b013e3280145b5d.
7
Contribution of alcohol use to the global burden of cirrhosis and liver cancer from 1990 to 2019 and projections to 2044.1990 年至 2019 年期间，饮酒对全球肝硬化和肝癌负担的贡献以及对 2044 年的预测。
Hepatol Int. 2023 Aug;17(4):1028-1044. doi: 10.1007/s12072-023-10503-2. Epub 2023 Mar 5.
8
Clinical Implications of Concomitant Alcohol Use, Obesity, and Viral Hepatitis.酒精使用、肥胖与病毒性肝炎并存的临床意义
Gastroenterology. 2016 Jun;150(8):1718-22. doi: 10.1053/j.gastro.2016.02.001. Epub 2016 Feb 10.
9
Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis.酒精作为肝硬化的一个风险因素：一项系统评价和荟萃分析。
Drug Alcohol Rev. 2010 Jul;29(4):437-45. doi: 10.1111/j.1465-3362.2009.00153.x.
10
Global, regional, and national burden of cirrhosis and other chronic liver diseases due to alcohol use, 1990-2019: a systematic analysis for the Global Burden of Disease study 2019.全球、区域和国家因饮酒导致的肝硬化和其他慢性肝病负担，1990-2019 年：2019 年全球疾病负担研究的系统分析。
BMC Gastroenterol. 2022 Nov 23;22(1):484. doi: 10.1186/s12876-022-02518-0.
引用本文的文献
1
3PM-guided innovation in treatments of severe alcohol-associated hepatitis utilizing fecal microbiota transplantation.利用粪便微生物群移植在严重酒精性肝炎治疗中进行以精准医学为导向的创新。
EPMA J. 2024 Oct 31;15(4):677-692. doi: 10.1007/s13167-024-00381-5. eCollection 2024 Dec.
2
Global and regional burden of alcohol-associated liver disease and alcohol use disorder in the elderly.老年人酒精性肝病和酒精使用障碍的全球及区域负担
JHEP Rep. 2024 Jan 26;6(4):101020. doi: 10.1016/j.jhepr.2024.101020. eCollection 2024 Apr.
本文引用的文献
1
Contribution of alcohol use to the global burden of cirrhosis and liver cancer from 1990 to 2019 and projections to 2044.1990 年至 2019 年期间，饮酒对全球肝硬化和肝癌负担的贡献以及对 2044 年的预测。
Hepatol Int. 2023 Aug;17(4):1028-1044. doi: 10.1007/s12072-023-10503-2. Epub 2023 Mar 5.
2
Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors.全球酒精性肝硬化和 HCC 的流行病学：趋势、预测和危险因素。
Nat Rev Gastroenterol Hepatol. 2023 Jan;20(1):37-49. doi: 10.1038/s41575-022-00688-6. Epub 2022 Oct 18.
3
Covid-19 and alcohol associated liver disease.Covid-19 与酒精相关的肝病。
Dig Liver Dis. 2022 Nov;54(11):1459-1468. doi: 10.1016/j.dld.2022.07.007. Epub 2022 Aug 4.
4
Racial and Health Disparities among Cirrhosis-related Hospitalizations in the USA.美国肝硬化相关住院治疗中的种族与健康差异
J Clin Transl Hepatol. 2022 Jun 28;10(3):398-404. doi: 10.14218/JCTH.2021.00227. Epub 2022 Jan 4.
5
Diagnosis and Treatment of Alcohol-Associated Liver Disease: A Review.酒精相关性肝病的诊断与治疗：综述
JAMA. 2021 Jul 13;326(2):165-176. doi: 10.1001/jama.2021.7683.
6
Impact of Public Health Policies on Alcohol-Associated Liver Disease in Latin America: An Ecological Multinational Study.公共卫生政策对拉丁美洲酒精性肝病的影响：一项多国生态研究
Hepatology. 2021 Nov;74(5):2478-2490. doi: 10.1002/hep.32016. Epub 2021 Aug 22.
7
Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis?2019冠状病毒病大流行期间的酒精使用与滥用：一场潜在的公共卫生危机？
Lancet Public Health. 2020 May;5(5):e259. doi: 10.1016/S2468-2667(20)30088-8. Epub 2020 Apr 8.
8
Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults.美国住院成年人群慢性肝脏疾病负担的变化趋势。
JAMA Netw Open. 2020 Apr 1;3(4):e201997. doi: 10.1001/jamanetworkopen.2020.1997.
9
Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD.2012 年至 2017 年全球慢性肝病负担的变化：非酒精性脂肪性肝病的影响日益增加。
Hepatology. 2020 Nov;72(5):1605-1616. doi: 10.1002/hep.31173. Epub 2020 Oct 27.
10
Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study.全球 1990 年至 2017 年期间的酒精暴露情况及 2030 年预测：一项建模研究。
Lancet. 2019 Jun 22;393(10190):2493-2502. doi: 10.1016/S0140-6736(18)32744-2. Epub 2019 May 7.
Zotero 插件